NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
8-K - Wave Life Sciences Ltd. - 1.01 / 8.01 / 9.01
Filed:
2026-04-15
AccNo:
0001193125-26-157003
Size:
339 KB
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits
发布时间04/15 20:08 UTC
首次发现04/16 02:15 UTC
热度93.2
重要度78
情绪+0.02
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 741 字符
Form 8-K - Current report: SEC Accession No. 0001193125-26-157003
Filing Date: 2026-04-15
Accepted: 2026-04-15 16:08:07
Documents: 15
Period of Report: 2026-04-15
Items: Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Wave Life Sciences Ltd. (Filer) CIK : 0001631574 (see all company filings) EIN. : 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 26864230 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 8-K | d116643d8k.htm iXBRL | 8-K
2 | EX-2.1 | d116643dex21.htm | EX-2.1
3 | EX-99.1 | d116643dex991.htm | EX-99.1
7 | GRAPHIC | g116643g0414134417370.jpg | GRAPHIC